Effects of diverse psychopharmacological substances on the activity of brain prolyl oligopeptidase.
Peltonen I, Männistö PT.
Basic Clin Pharmacol Toxicol · research support, non-u.s. gov't; journal article · DOI 10.1111/j.1742-7843.2010.00626.x PUBLICATION REGISTRY
Go to research.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för ritanserin. Visa hela publikationsregistret
A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publications in the selection
5 hitsEffect of ritanserin, a 5HT2A/2C antagonist, on negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study.
Akhondzadeh S, Malek-Hosseini M, Ghoreishi A, Raznahan M, Rezazadeh SA.
Prog Neuropsychopharmacol Biol Psychiatry · research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1016/j.pnpbp.2008.08.020Ritanserin improves sleep quality in narcolepsy.
Mayer G.
Pharmacopsychiatry · clinical trial; research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1055/s-2003-41200Ritanserin, a serotonin-2 receptor antagonist, improves ultradian sleep rhythmicity in young poor sleepers.
Viola AU, Brandenberger G, Toussaint M, Bouhours P, Paul Macher J, Luthringer R.
Clin Neurophysiol · controlled clinical trial; clinical trial; journal article · DOI 10.1016/s1388-2457(02)00014-7Ritanserin and alcohol abuse and dependence.
Meert TF.
Alcohol Alcohol Suppl · review; journal article